Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication

Clinical Science

Volumn 126, Issue 12, 2014, Pages 845-855

  Choi, Steve S ^a,b   Claridge, Lee C ^c   Jhaveri, Ravi ^d   Swiderska Syn, Marzena ^a   Clark, Paul ^a   Suzuki, Ayako ^a,e   Pereira, Thiago A ^f,g   Mi, Zhiyong ^h   Kuo, Paul C ^h   Guy, Cynthia D ^a   Pereira, Fausto E L ^g   Diehl, Anna Mae ^a   Patel, Keyur ^a   Syn, Wing Kin ^a,i,j,k  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f INSTITUTO OSWALDO CRUZ   (Brazil)

^g FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^h LOYOLA UNIVERSITY CHICAGO   (United States)

ⁱ Institute of Hepatology Regeneration and Repair Group   (United Kingdom)

^j BARTS HEALTH NHS TRUST   (United Kingdom)

^k UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

more..

Author keywords

Fibrosis; Hedgehog; Hepatitis; Osteopontin; Replication

Indexed keywords

MESSENGER RNA; OSTEOPONTIN;

ADULT; ARTICLE; CELL FUNCTION; CELLULAR PERMISSIVENESS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER FIBROSIS; MALE; MIDDLE AGED; PRIORITY JOURNAL; RECEPTOR UPREGULATION; VIRUS REPLICATION;

ADULT; BASE SEQUENCE; DNA PRIMERS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; OSTEOPONTIN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; VIRUS REPLICATION;

EID: 84895116987     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130473     Document Type: Article

References (35)

1. Shepard, C. W., Finelli, L. and Alter, M. J. (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5, 558-567
2. Chen, S. L. and Morgan, T. R. (2006) The natural history of hepatitis C virus (HCV) infection. Int. J. Med. Sci. 3, 47-52
3. Pawlotsky, J. M. (2011) Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus. Hepatology 53, 1742-1751
4. Diehl, A. M. and Chute, J. (2013) Underlying potential: cellular and molecular determinants of adult liver repair. J. Clin. Invest. 123, 1858-1860
5. Choi, S. S., Omenetti, A., Syn, W. K. and Diehl, A. M. (2011) The role of Hedgehog signaling in fibrogenic liver repair. Int. J. Biochem. Cell Biol 43, 238-244
6. Choi, S. S., Omenetti, A., Witek, R. P., Moylan, C. A., Syn, W. K., Jung, Y., Yang, L., Sudan, D. L., Sicklick, J. K., Michelotti, G. A. et al. (2009) Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G1093-G1106
7. Omenetti, A., Syn, W. K., Jung, Y., Francis, H., Porrello, A., Witek, R. P., Choi, S. S., Yang, L., Mayo, M. J., Gershwin, M. E. et al. (2009) Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology 50, 518-527
8. Syn, W. K., Choi, S. S., Liaskou, E., Karaca, G. F., Agboola, K. M., Oo, Y. H., Mi, Z., Pereira, T. A., Zdanowicz, M., Malladi, P. et al. (2011) Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology 53, 106-115
9. Patouraux, S., Bonnafous, S., Voican, C. S., Anty, R., Saint-Paul, M. C., Rosenthal-Allieri, M. A., Agostini, H., Njike, M., Barri-Ova, N. and Naveau, S. (2012) The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS ONE 7, e35612
10. Pritchett, J., Harvey, E., Athwal, V., Berry, A., Rowe, C., Oakley, F., Moles, A., Mann, D. A., Bobola, N., Sharrocks, A. D. et al. (2012) Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Hepatology 56, 1108-1116
11. Zhao, L., Li, T., Wang, Y., Pan, Y., Ning, H., Hui, X., Xie, H., Wang, J., Han, Y., Liu, Z. and Fan, D. (2008) Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int. J. Clin. Pract. 62, 1056-1062
12. Nagoshi, S. (2014) Osteopontin: versatile modulator of liver diseases. Hepatol. Res. 44, 22-30
13. Shang, S., Plymoth, A., Ge, S., Feng, Z., Rosen, H. R., Sangrajrang, S., Hainaut, P., Marrero, J. A. and Beretta, L. (2012) Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology 55, 483-490
14. Weber, G. F., Lett, G. S. and Haubein, N. C. (2011) Categorical meta-analysis of Osteopontin as a clinical cancer marker. Oncol. Rep. 25, 433-441
15. Choi, S. S., Bradrick, S., Qiang, G., Mostafavi, A., Chaturvedi, G., Weinman, S. A., Diehl, A. M. and Jhaveri, R. (2011) Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication. Hepatology 54, 1580-1590
16. Pereira Tde, A., Witek, R. P., Syn, W. K., Choi, S. S., Bradrick, S., Karaca, G. F., Agboola, K. M., Jung, Y., Omenetti, A., Moylan, C. A. et al. (2010) Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma. Lab. Invest. 90, 1690-1703
17. Shaker, O. G., Sadik, N. A. and El-Dessouki, A. (2012) Single-nucleotide polymorphism in the promoter region of the osteopontin gene at nucleotide -443 as a marker predicting the efficacy of pegylated interferon/ribavirin-therapy in Egyptians patients with chronic hepatitis C. Hum. Immunol. 73, 1039-1045
18. Blight, K. J., McKeating, J. A. and Rice, C. M. (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76, 13001-13014
19. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H. G., Mizokami, M. et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791-796
20. Kato, T., Date, T., Murayama, A., Morikawa, K., Akazawa, D. and Wakita, T. (2006) Cell culture and infection system for hepatitis C virus. Nat. Protoc. 1, 2334-2339
21. Mi, Z., Guo, H., Russell, M. B., Liu, Y., Sullenger, B. A. and Kuo, P. C. (2009) RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells. Mol. Ther. 17, 153-161
22. Talbot, L. J., Mi, Z., Bhattacharya, S. D., Kim, V., Guo, H. and Kuo, P. C. (2011) Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells. Surgery 150, 224-230
23. Syn, W. K., Agboola, K. M., Swiderska, M., Michelotti, G. A., Liaskou, E., Pang, H., Xie, G., Philips, G., Chan, I. S., Karaca, G. F. et al. (2012) NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut 61, 1323-1329
24. The French METAVIR Cooperative Study Group (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20, 15-20
25. Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W. and Wollman, J. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1, 431-435
26. Syn, W. K., Jung, Y., Omenetti, A., Abdelmalek, M., Guy, C. D., Yang, L., Wang, J., Witek, R. P., Fearing, C. M., Pereira, T. A. et al. (2009) Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology 137, 1478-1488
27. Petta, S. and Craxi, A. (2013) How to optimize HCV therapy in genotype 1 patients: predictors of response. Liver Int. 33 (Suppl. 1), 23-29
28. Lalor, P. F., Faint, J., Aarbodem, Y., Hubscher, S. G. and Adams, D. H. (2007) The role of cytokines and chemokines in the development of steatohepatitis. Semin. Liver Dis. 27, 173-193
29. Kukla, M., Mazur, W., Buldak, R. J. and Zwirska-Korczala, K. (2011) Potential role of leptin, adiponectin and three novel adipokines - visfatin, chemerin and vaspin - in chronic hepatitis. Mol. Med. 17, 1397-1410
30. Rowe, I. A., Galsinh, S. K., Wilson, G. K., Parker, R., Durant, S., Lazar, C., Branza-Nichita, N., Bicknell, R., Adams, D. H., Balfe, P. and McKeating, J. A. (2014) Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication. Hepatology 59, 375-384
31. Lazaro, C. A., Chang, M., Tang, W., Campbell, J., Sullivan, D. G., Gretch, D. R., Corey, L., Coombs, R. W. and Fausto, N. (2007) Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am. J. Pathol. 170, 478-489
32. Bukong, T. N., Kodys, K. and Szabo, G. (2013) Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection. Hepatology 58, 1569-1579
33. Tsukita, S. and Yonemura, S. (1997) ERM proteins: head-to-tail regulation of actin-plasma membrane interaction. Trends Biochem. Sci. 22, 53-58
34. Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J. et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399-401
35. Corbetta, S., Redaelli, A., Pozzi, M., Bovo, G., Ratti, L., Redaelli, E., Pellegrini, C., Beck-Peccoz, P. and Spada, A. (2011) Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection. Eur J. Clin. Invest. 41, 898-905